Concepedia
Statistics
Publications
17
Citations
591
H-Index
14
Active since
1999
Affiliations
Eli Lilly (United States)(Current)
University of Rochester
University of Michigan
Pfizer (United States)
The Ohio State University
David C. Sperry is an author at Eli Lilly (United States) specializing in pharmacy, pharmaceutics, and bioavailability.
Publications per year
1999–2022
Relative bioavailability estimation of carbamazepine crystal forms using an artificial stomach-duodenum model
Stephen R. Carino, David C. Sperry, Michael Hawley · Journal of Pharmaceutical Sciences · 2005 · 132 citations
Pharmacy, Pharmacokinetics, Pharmacology +16
Relative Bioavailability of Three Different Solid Forms of PNU-141659 as Determined with the Artificial Stomach-Duodenum Model
Stephen R. Carino, David C. Sperry, Michael Hawley · Journal of Pharmaceutical Sciences · 2010 · 57 citations · Full text
Pharmacy, Pharmacokinetics, Pharmacology +8
FIP Guidelines for Dissolution Testing of Solid Oral Products
Horst Dieter Friedel, Cynthia K. Brown, Amy R. Barker et al. · Journal of Pharmaceutical Sciences · 2018 · 56 citations
Pharmacy, Pharmaceutics, Bioavailability +14
Use of Artificial Stomach−Duodenum Model for Investigation of Dosing Fluid Effect on Clinical Trial Variability
Christopher S. Polster, Faraj Atassi, Sy-Juen Wu et al. · Molecular Pharmaceutics · 2010 · 54 citations
Pharmacy, Pharmacokinetics, Pharmacology +15
Spectroscopic studies of mass selected clusters of Sr+ solvated by H2O and D2O
David C. Sperry, Anthony J. Midey, James I. Lee et al. · The Journal of Chemical Physics · 1999 · 51 citations
Natural Sciences, Chemistry, Physics +14
1–5 of 17